References. The Association for Medical Education and Research in Substance Abuse (AMERSA):

Transcription

1 References American Nurses Association & International Nurses Society on Addictions. (2013). Addictions Nursing: Scope and Standard of Practice (3rd Ed.). American Society of Addiction Medicine: American Society of Addiction Medicine (2015). National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. Available online: source/practice support/guidelines and consensusdocs/asam national practice guideline supplement.pdf?sfvrsn=24 America's deadliest drug problem: our view Opioids kill nearly as many as guns or auto accidents (2015, December 22). [Editorial]. USA Today. American Psychiatric Nurses Association, Substance use resources: The Association for Medical Education and Research in Substance Abuse (AMERSA): Beletsky, L., Davis, C. S., Anderson, E., & Burris, S. (2008). The Law (and Politics) of Safe Injection Facilities in the United States. American Journal of Public Health American 98(2), doi: /ajph Boekel, L. C., Brouwers, E. P., Weeghel, J. V., & Garretsen, H. F. (2014). Healthcare professionals regard towards working with patients with substance use disorders: Comparison of primary care, general psychiatry and specialist addiction services. Drug and Alcohol Dependence, 134, doi: /j.drugalcdep Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The Changing Face of Heroin Use in the United States. JAMA Psychiatry, 71(7), doi: /jamapsychiatry Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) Rockville, MD: Substance Abuse and Mental Health Services Administration, Connock, M., Juarez Garcia, A., Jowett, S., et al. (2007).Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technology Assess 11: Dowell, D., Haegerich, T., & Chou, R. CDC Guideline for Prescribing Opioids for Chronic Pain United States, MMWR Recomm Rep 2016:65 (No. RR 1):1 49. DOI:

2 Drug addiction a disease, not a moral failing, white house says (2012, June 11). [Editorial]. LA Times. Available online: pn drug addiction adisease not a moral failing white house says Ford, R., Bammer, G., & Becker, N. (2008). The determinants of nurses therapeutic attitude to patients who use illicit drugs and implications for workforce development. Journal of Clinical Nursing, 17(18), doi: /j x Galloway, J. (2016). Left Behind: Communities Overlooked by Response to Opioid Epidemic. The Fix. Retrieved March 4, 2016, from overlookedgovernment response opioid overdose crisis Gottleib. (n.d.). Strength Based Nursing a Holistic Approach to Care, Grounded in Eight Core Values. American Journal of Nursing, 114(8), International Nurses Society on Addictions: Jones, C. M., Campopiano, M., Baldwin, G., & Mccance Katz, E. (2015). National and State Treatment Need and Capacity for Opioid Agonist Medication Assisted Treatment. American Journal of Public Health, 105(8), E55 E63. doi: /ajph Kennedy, S., Hardiker, N., & Staniland, K. (2015). Empowerment an essential ingredient in the clinical environment: A review of the literature. Nurse Education Today, 35(3), doi: /j.nedt Levy, B., Paulozzi, L., Mack, K., & Jones, C. (2015). Trends in opioid analgesic prescribing rates by specialty, U.S., American Journal of Prevention Medicine, 49: Linnen, D., & Rowley, A. (2013). Making a Case for Nurse Empowerment. Nursing 2013, Longo, D. L., Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016). Relationship between Nonmedical Prescription Opioid Use and Heroin Use. New England Journal of Medicine, 374(2), doi: /nejmra Lovi, R., & Barr, J. (n.d.). Stigma Reported by Nurses Related to those Experiencing Drug and Alcohol Dependency: A Phenomenological Giorgi Study. Contemporary Nurse, 33(2), Melnyk, B. M., & Finehout Overholt, E. (2005). Evidence Based Practice in Nursing and Healthcare. Lippincott, Williams & Wilkins: Philadelphia, PA. Malloch, K., & Porter O Grady, T. (2006). Introduction to Evidence Based Practice in Nursing and Healthcare. Jones and Bartlett:Sudbury, MA. Montani, F., Courcy, F., Giorgi, G., & Boilard, A. (2015). Enhancing nurses' empowerment: The role of supervisors' empowering management practices. Journal of Advanced Nursing, 71(9), doi: /jan.12665

3 Neville, K., & Roan, N. (2014). Challenges in Nursing Practice. The Journal of Nursing Administration, 44(6), doi: /nna Olsen, Y., & Sharfstein, J. M. (2014). Viewpoint: Confronting the stigma of opioid use disorder and its treatment. Journal of the American Medical Association, 311(14), Retrieved January 04, 2016, Park, J. & Bloch, M. (2016, January 19). How the Epidemic of Drug Overdose Deaths Ripples Across America. New York Times. Retrieved from overdose deaths in theus.html?_r=0 Payte, J. T. (1991). The Use of Insulin in the Treatment of Diabetes: An Analogy to Methadone Maintenance. Journal of Psychoactive Drugs, 23(2), doi: / Prescription Drug Abuse and Heroin Use. (2015, October/November). Retrieved from press office/2015/10/21presidential memorandum addressingprescription drug abuse and heroin Providers Clinical Support System for Medication Assisted Treatment: SAMHSA. (n.d.). Advisory, Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update, 15(1), Retrieved March 1, Seelye, K. (2016, March 25). Heroin Epidemic Is Yielding to a Deadlier Cousin: Fentanyl. New York Times. Retrieved from fentanyl.html VA/DOD Clinical Practice Guidelines Management of Substance Use Disorder (2015). Retrieved from quality.va.gov/guidelines/mh/sud Young, A., Chaudhry, H. J., Pei, X., Haibesieben, K., Polk, D. H., & Dugan, M. (n.d.). A Census of Actively Licensed Physicians in the United States, Journal of Medical Regulation, 101(2), Zweben, J. E., & Payte, J. T. (n.d.). Opioid maintenance treatment. In J. Martin (Author), Pharmacologic Interventions in Addiction (pp ). doi:

4 Naloxone References Beletsky, L., Ruthazer, R., Macalino, G., et al. (2007).Physicians knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. Journal of Urban Health. 84(1): Centers for Disease Control and Prevention. Announcements: opioid overdose prevention toolkit released. MMWR. October Accessed March 10, Centers for Disease Control and Prevention. (2012).Community based opioid overdose prevention programs providing naloxone United States, MMWR, 61(6): European Monitoring Centre for Drugs and Drug Addiction (2015), Preventing fatal overdoses: a systematic review of the effectiveness of take home naloxone, EMCDDA Papers, Publications Office of the European Union, Luxembourg. Retrieved from papers/naloxone effectiveness Green, T., Heimer, R., & Grau, L. (2008). Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction, 103(6): Naloxone hydrochloride (naloxone hydrochloride injection) [prescribing information]. Lake Forest, IL: Hospira, Inc; Substance Abuse and Mental Health Services Administration. Opioid overdose toolkit: information for prescribers. Overdose Prevention Toolkit/SMA Accessed March 10, Walley, A., Xuan, Z., Hackman, H., et al. (2013).Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. British Medical Journal, 346:f174. Wermeling, D. P. (2015). Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access. Therapeutic Advances in Drug Safety, 6(1),

5 References: Pain Guidelines American College of Occupational and Environmental Medicine. ACOEM Guidelines for Chronic Use of Opioids. Guidelines_Opioids.aspx. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. (2009) Journal of the American Geriatrics Society. 57: American Society of Anesthesiologists Task Force on Chronic Pain Management. (2010) Anesthesiology, 112: ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. ASAM, May 27, Berland, D., Rodgers, P. (2012) Managing Chronic Non Terminal Pain in Adults, Including Prescribing Controlled Substances. Retrieved from Guideline for Clinical Care Ambulatory University of Michigan Health System. Chou, R. et al. (2009).Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. The Journal of Pain, Volume 10(2) e22 doi.org/ %2fj.jpain Department of Veterans Affairs, Department of Defense. Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain. Washington, DC: Department of Defense; (Online at er.pdf) Fine, P., Portenoy, R. (2009).Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation. Establishing best practices for opioid rotation: conclusions of an expert panel. Journal of Pain and Symptom Management, 38: Hooten, W., et al. (2013). Institute for Clinical Systems Improvement. Assessment and Management of Chronic Pain. Updated November Retrieved from Manchikanti, L., et al (2012).American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non cancer pain: Part I evidence assessment. Pain Physician, 15:S1 65. Manchikanti, L., et al (2012).American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non cancer pain: Part II guidance. Pain Physician, 15:S67 S116.

6 Rolfs, R., Johnson, E., Williams, N., & Sundwall, D. (2010) Utah clinical guidelines on prescribing opioids for treatment of pain. Journal of Pain and Palliative Care Pharmacotherapy, 24(3) doi.org/ /